Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-024664
Filing Date
2025-05-12
Accepted
2025-05-12 16:07:29
Documents
102
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aqst-20250331.htm   iXBRL 10-Q 1183540
2 EX-10.1 mschobelsignedconsulting.htm EX-10.1 13114
3 EX-31.1 q12025ex311.htm EX-31.1 10877
4 EX-31.2 q12025ex312.htm EX-31.2 11093
5 EX-32.1 q12025ex321.htm EX-32.1 6374
6 EX-32.2 q12025ex322.htm EX-32.2 6440
12 mschobelsignedconsulting001.jpg GRAPHIC 305229
13 mschobelsignedconsulting002.jpg GRAPHIC 286074
14 mschobelsignedconsulting003.jpg GRAPHIC 107213
15 mschobelsignedconsulting004.jpg GRAPHIC 169327
  Complete submission text file 0001628280-25-024664.txt   9029113

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250331.xsd EX-101.SCH 68411
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aqst-20250331_cal.xml EX-101.CAL 64755
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aqst-20250331_def.xml EX-101.DEF 386614
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250331_lab.xml EX-101.LAB 747487
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250331_pre.xml EX-101.PRE 587188
104 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250331_htm.xml XML 947196
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 25934805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)